1 study found for:    CARDIOMYOPATHY, DILATED, 2A
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Conditions: Heart Failure, Congestive;   Dilated Cardiomyopathy
Interventions: Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study);   Procedure: Placebo Infusion;   Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)

Indicates status has not been verified in more than two years